Cargando…

Whole body diffusion weighted MRI – a new view of myeloma

The recent consensus statement from the International Myeloma Working Group has introduced the role of whole body (WB) magnetic resonance imaging (MRI) into the management pathway for patients with multiple myeloma. The speed, coverage and high sensitivity of WB diffusion weighted (DW)‐MRI and the u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messiou, Christina, Kaiser, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737237/ https://www.ncbi.nlm.nih.gov/pubmed/26013304 http://dx.doi.org/10.1111/bjh.13509

Ejemplares similares

Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma
por: Ahmed, Naeem, et al.
Publicado: (2019)

Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma
por: Otero, S, et al.
Publicado: (2015)

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
por: Pawlyn, C, et al.
Publicado: (2016)

Inter-observer agreement of baseline whole body MRI in multiple myeloma
por: Croft, James, et al.
Publicado: (2020)

Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI
por: Winfield, Jessica M., et al.
Publicado: (2017)

Improving real‐world myeloma patient access to whole body MRI through “open‐access” knowledge sharing: The UK experience
por: Kaiser, Martin F, et al.
Publicado: (2020)

Repeatability and reproducibility of apparent diffusion coefficient and fat fraction measurement of focal myeloma lesions on whole body magnetic resonance imaging
por: Barwick, Tara, et al.
Publicado: (2021)

Accelerating Whole-Body Diffusion-weighted MRI with Deep Learning–based Denoising Image Filters
por: Zormpas-Petridis, Konstantinos, et al.
Publicado: (2021)

Development of machine learning support for reading whole body diffusion-weighted MRI (WB-MRI) in myeloma for the detection and quantification of the extent of disease before and after treatment (MALIMAR): protocol for a cross-sectional diagnostic test accuracy study
por: Satchwell, Laura, et al.
Publicado: (2022)

Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
por: Knill, Annemarie K., et al.
Publicado: (2022)

Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma
por: Lai, Alta Y. T., et al.
Publicado: (2019)

Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
por: Mulé, Sébastien, et al.
Publicado: (2020)

Whole body MRI: Improved Lesion Detection and Characterization With Diffusion Weighted Techniques
por: Attariwala, Rajpaul, et al.
Publicado: (2013)

Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI
por: Takasu, Miyuki, et al.
Publicado: (2020)

Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma
por: Wang, Jiping, et al.
Publicado: (2021)

Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
por: Stecco, Alessandro, et al.
Publicado: (2018)

Whole-body MRI and diffusion MRI
por: Padhani, Anwar R
Publicado: (2014)

Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma
por: Rata, Mihaela, et al.
Publicado: (2022)

Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden
por: Giles, S.L., et al.
Publicado: (2015)

Repeatability and test–retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI)
por: ElGendy, Khalil, et al.
Publicado: (2022)

Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
por: Keaveney, Sam, et al.
Publicado: (2023)

Whole-body diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma
por: Costachescu, Dan, et al.
Publicado: (2021)

The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently
por: Zhang, Bei, et al.
Publicado: (2022)

Evaluation of whole-body MRI with diffusion-weighted sequences in the staging of pediatric cancer patients
por: de Oliveira, Alex Dias, et al.
Publicado: (2020)

Whole-body diffusion-weighted imaging for staging malignant lymphoma in children
por: Kwee, Thomas C., et al.
Publicado: (2010)

Whole-body diffusion-weighted imaging in lymphoma
por: Lin, C., et al.
Publicado: (2010)

Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma
por: Mosavi, Firas, et al.
Publicado: (2013)

Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases
por: Dresen, Raphaëla Carmen, et al.
Publicado: (2019)

Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors
por: Carlbom, Lina, et al.
Publicado: (2017)

Whole-body diffusion-weighted MRI for staging of women with cancer during pregnancy: a pilot study
por: Dresen, RC, et al.
Publicado: (2015)

Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases
por: Donners, Ricardo, et al.
Publicado: (2023)

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2021)

Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy
por: Zhang, Huan, et al.
Publicado: (2018)

Diffusion-Weighted MRI in the Genitourinary System
por: De Perrot, Thomas, et al.
Publicado: (2022)

Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT
por: Michielsen, K, et al.
Publicado: (2015)

Whole-body diffusion-weighted MRI versus CT for detection, restaging and operability assessment of recurrent ovarian carcinoma
por: Michielsen, K, et al.
Publicado: (2014)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

Whole body MRI in multiple myeloma: Optimising image acquisition and read times
por: Singh, Saurabh, et al.
Publicado: (2020)

11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer
por: Wieder, Hinrich, et al.
Publicado: (2017)

Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant
por: Mesguich, Charles, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bav4kbvpsqqnntb18vhpjs7hu6